Lyso-Gb3 is as a primary biomarker for Fabry disease screening among high-risk contingents

Autor:	Tatyana Podkletnova, Alexander Pushkov, Kirill Savostyanov, Sergey Moiseev, Lolita Pak, Natalya N Mazanova, Alexey Sukhozhenko, Alexander Pakhomov, L. M. Kuzenkova
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty Primary (chemistry) business.industry Endocrinology Diabetes and Metabolism Lyso gb3 medicine.disease Biochemistry Fabry disease Endocrinology Internal medicine Genetics medicine Biomarker (medicine) business Molecular Biology
Zdroj:	Molecular Genetics and Metabolism. 126:S130
ISSN:	1096-7192
DOI:	10.1016/j.ymgme.2018.12.333
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e7a459195b621de757b91f7f2a294f03 https://doi.org/10.1016/j.ymgme.2018.12.333 Zobrazit plný text záznamu Full Text from ScienceDirect